메뉴 건너뛰기




Volumn 97, Issue 3, 2006, Pages 640-643

Chemopreventive effects of cyclooxygenase-2 inhibitor and epidermal growth factor-receptor kinase inhibitor on rat urinary bladder carcinogenesis

Author keywords

Bladder cancer; Chemoprevention; Cyclooxygenase 2; Epidermal growth factor receptor

Indexed keywords

CARCINOGEN; CYCLOOXYGENASE 2 INHIBITOR; DRINKING WATER; DRUG VEHICLE; EOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FORMALDEHYDE; GEFITINIB; HEMATOXYLIN; MELOXICAM; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE;

EID: 33645007678     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06053.x     Document Type: Article
Times cited : (20)

References (25)
  • 1
    • 0034671806 scopus 로고    scopus 로고
    • Cox-2 is expressed in human pulmonary, colonic, and mammary tumors
    • Soslow RA Dannenberg AJ Rush D et al. Cox-2 is expressed in human pulmonary, colonic, and mammary tumors Cancer 2000 89 2637 45
    • (2000) Cancer , vol.89 , pp. 2637-45
    • Soslow, R.A.1    Dannenberg, A.J.2    Rush, D.3
  • 2
    • 0037295004 scopus 로고    scopus 로고
    • Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer
    • Steele VE Hawk ET Viner JL Lubbet RA Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer Mutat Res 2003 523-524 137 44
    • (2003) Mutat Res , vol.523-524 , pp. 137-44
    • Steele, V.E.1    Hawk, E.T.2    Viner, J.L.3    Lubbet, R.A.4
  • 3
    • 0035183413 scopus 로고    scopus 로고
    • Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs
    • Garcia-Rodriguez LA Huerta-Alvarez C Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs Epidemiology 2001 12 88 93
    • (2001) Epidemiology , vol.12 , pp. 88-93
    • Garcia-Rodriguez, L.A.1    Huerta-Alvarez, C.2
  • 4
    • 0032815072 scopus 로고    scopus 로고
    • Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis
    • Fischer SM Lo HH Gordon GB et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis Mol Carcinog 1999 25 231 40
    • (1999) Mol Carcinog , vol.25 , pp. 231-40
    • Fischer, S.M.1    Lo, H.H.2    Gordon, G.B.3
  • 7
    • 0034099597 scopus 로고    scopus 로고
    • Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder
    • Shirahama T Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder Clin Cancer Res 2000 6 2424 30
    • (2000) Clin Cancer Res , vol.6 , pp. 2424-30
    • Shirahama, T.1
  • 8
    • 0033401645 scopus 로고    scopus 로고
    • Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine
    • Kitayama W Denda A Okajima E Tsujiuchi T Konishi Y Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine Carcinogenesis 1999 20 2305 10
    • (1999) Carcinogenesis , vol.20 , pp. 2305-10
    • Kitayama, W.1    Denda, A.2    Okajima, E.3    Tsujiuchi, T.4    Konishi, Y.5
  • 9
    • 0037366062 scopus 로고    scopus 로고
    • Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder
    • Shariat SF Kim JH Ayala GE Kho K Wheeler TM Lerner SP Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder J Urol 2003 169 938 42
    • (2003) J Urol , vol.169 , pp. 938-42
    • Shariat, S.F.1    Kim, J.H.2    Ayala, G.E.3    Kho, K.4    Wheeler, T.M.5    Lerner, S.P.6
  • 10
    • 0034667354 scopus 로고    scopus 로고
    • Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats
    • Grubbs CJ Lubet RA Koki AT et al. Celecoxib inhibits N-butyl-N-(4- hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats Cancer Res 2000 60 5599 602
    • (2000) Cancer Res , vol.60 , pp. 5599-602
    • Grubbs, C.J.1    Lubet, R.A.2    Koki, A.T.3
  • 11
    • 0031725297 scopus 로고    scopus 로고
    • Exogenous epidermal growth factor exerts promoting action during the early phase of rat urinary bladder carcinogenesis
    • Hattori K Fujimoto K Tamatani T Rademaker A Oyasu R Exogenous epidermal growth factor exerts promoting action during the early phase of rat urinary bladder carcinogenesis Jpn J Cancer Res 1998 89 991 4
    • (1998) Jpn J Cancer Res , vol.89 , pp. 991-4
    • Hattori, K.1    Fujimoto, K.2    Tamatani, T.3    Rademaker, A.4    Oyasu, R.5
  • 12
    • 0030980531 scopus 로고    scopus 로고
    • Significance of urinary of epidermal growth factor and its receptor expression in human bladder cancer
    • Chow NH Liu HS Chang CJ et al. Significance of urinary of epidermal growth factor and its receptor expression in human bladder cancer Anticancer Res 1997 17 1293 6
    • (1997) Anticancer Res , vol.17 , pp. 1293-6
    • Chow, N.H.1    Liu, H.S.2    Chang, C.J.3
  • 13
    • 0030608636 scopus 로고    scopus 로고
    • Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide
    • Dinney CP Parker C Dong Z et al. Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide Clin Cancer Res 1997 3 161 8
    • (1997) Clin Cancer Res , vol.3 , pp. 161-8
    • Dinney, C.P.1    Parker, C.2    Dong, Z.3
  • 14
    • 0036005846 scopus 로고    scopus 로고
    • ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer
    • Raben D Helfrich BA Chan D Johnson G Bunn PA ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer Semin Oncol 2002 29 Suppl. 4 37 46
    • (2002) Semin Oncol , vol.29 , Issue.4 SUPPL. , pp. 37-46
    • Raben, D.1    Helfrich, B.A.2    Chan, D.3    Johnson, G.4    Bunn, P.A.5
  • 15
    • 0036569870 scopus 로고    scopus 로고
    • ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: Results of a phase I trial
    • Ranson M Hammond LA Ferry D et al. ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial J Clin Oncol 2002 20 2240 50
    • (2002) J Clin Oncol , vol.20 , pp. 2240-50
    • Ranson, M.1    Hammond, L.A.2    Ferry, D.3
  • 16
    • 0033827119 scopus 로고    scopus 로고
    • Combinatorial chemoprevention of intestinal neoplasia
    • Torrance CJ Jackson PE Montgomery E et al. Combinatorial chemoprevention of intestinal neoplasia Nat Med 2000 6 1024 8
    • (2000) Nat Med , vol.6 , pp. 1024-8
    • Torrance, C.J.1    Jackson, P.E.2    Montgomery, E.3
  • 17
    • 0036313660 scopus 로고    scopus 로고
    • Telomerase is upregulated in irreversible preneoplastic lesions during bladder carcinogenesis in rats
    • Shimazui T Ami Y Miyanaga N Ideyama Y Nakahara T Akaza H Telomerase is upregulated in irreversible preneoplastic lesions during bladder carcinogenesis in rats Jpn J Cancer Res 2002 93 495 500
    • (2002) Jpn J Cancer Res , vol.93 , pp. 495-500
    • Shimazui, T.1    Ami, Y.2    Miyanaga, N.3    Ideyama, Y.4    Nakahara, T.5    Akaza, H.6
  • 18
    • 2442486078 scopus 로고    scopus 로고
    • COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro
    • Mohseni H Zaslau S McFadden D Riggs DR Jackson BJ Kandzari S COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro J Surg Res 2004 119 138 42
    • (2004) J Surg Res , vol.119 , pp. 138-42
    • Mohseni, H.1    Zaslau, S.2    McFadden, D.3    Riggs, D.R.4    Jackson, B.J.5    Kandzari, S.6
  • 20
    • 0032528189 scopus 로고    scopus 로고
    • Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine
    • Okajima E Denda A Ozono S et al. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine Cancer Res 1998 58 3028 31
    • (1998) Cancer Res , vol.58 , pp. 3028-31
    • Okajima, E.1    Denda, A.2    Ozono, S.3
  • 21
    • 0034526574 scopus 로고    scopus 로고
    • Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression
    • el-Marjou A Delouvee A Thiery JP Radvanyi F Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression Carcinogenesis 2000 21 2211 8
    • (2000) Carcinogenesis , vol.21 , pp. 2211-8
    • El-Marjou, A.1    Delouvee, A.2    Thiery, J.P.3    Radvanyi, F.4
  • 22
    • 0037298141 scopus 로고    scopus 로고
    • New directions for ZD1839 in the treatment of solid tumors
    • Schiller JH New directions for ZD1839 in the treatment of solid tumors Sem Oncol 2003 30 Suppl. 1 49 55
    • (2003) Sem Oncol , vol.30 , Issue.1 SUPPL. , pp. 49-55
    • Schiller, J.H.1
  • 23
    • 2442565728 scopus 로고    scopus 로고
    • Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2
    • Nutt JE Lazarowicz HP Mellon JK Lunec J Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2 Br J Cancer 2004 90 1679 85
    • (2004) Br J Cancer , vol.90 , pp. 1679-85
    • Nutt, J.E.1    Lazarowicz, H.P.2    Mellon, J.K.3    Lunec, J.4
  • 24
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch TJ Bell DW Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N Engl J Med 2004 350 2129 39
    • (2004) N Engl J Med , vol.350 , pp. 2129-39
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3
  • 25
    • 0037214178 scopus 로고    scopus 로고
    • Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: Potential targets for chemoprevention and systemic therapy
    • Richardson CM Sharma RA Cox G O'Byrne KJ Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy Lung Cancer 2003 39 1 13
    • (2003) Lung Cancer , vol.39 , pp. 1-13
    • Richardson, C.M.1    Sharma, R.A.2    Cox, G.3    O'Byrne, K.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.